Pharma company

AstraZeneca to buy China’s Gracell Bio for up to $1.2 billion

by
AstraZeneca to buy China’s Gracell Bio for up to $1.2 billion

London: AstraZeneca said on Tuesday it will buy Gracell Biotechnologies for up to $1.2 billion as the Anglo-Swedish pharma company furthers its cell therapy ambitions and boosts its presence in China, the world’s second-largest pharmaceuticals market. The cash deal, which adds several experimental therapies to AstraZeneca’s portfolio, values Gracell at $2 per ordinary share, or … Read more

Social Media Conversations – The New Research Tool for Pharma Sector – ET HealthWorld

by
social media conversations the new research tool for pharma sector

by Dr Ranjit Nair Nobody, not even a company can afford to stay away from social media, these days. The conversation happening on social media are the real world conversations especially during a time when the world is facing a pandemic. The importance of online public platforms and the conversation happening there cannot be missed. … Read more